Literature DB >> 23610020

Self-administration of intravenous C1 esterase inhibitor in hereditary angioedema.

Caroline Rizk1, Jacob Karsh, Stephanie Santucci, William Yang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23610020      PMCID： PMC3680557          DOI： 10.1503/cmaj.121364

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency.

Authors:  Marcel Levi; Goda Choi; Charles Picavet; C Erik Hack
Journal:  J Allergy Clin Immunol       Date:  2006-02-14       Impact factor: 10.793

Review 2.  Deep vein thrombosis associated with central venous catheters - a review.

Authors:  C J Rooden; M E T Tesselaar; S Osanto; F R Rosendaal; M V Huisman
Journal:  J Thromb Haemost       Date:  2005-06-24       Impact factor: 5.824

Review 3.  Clinical practice. Hereditary angioedema.

Authors:  Bruce L Zuraw
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

4.  Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.

Authors:  Henriette Farkas; László Jakab; György Temesszentandrási; Beáta Visy; György Harmat; George Füst; Gábor Széplaki; Béla Fekete; István Karádi; Lilian Varga
Journal:  J Allergy Clin Immunol       Date:  2007-08-29       Impact factor: 10.793

5.  [Cost-effectiveness analysis of home administration versus hospital administration of intravenous immunoglobulin].

Authors:  M Rodríguez; A Procupet; J Heras
Journal:  Med Clin (Barc)       Date:  1991-01-19       Impact factor: 1.725

6.  Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits.

Authors:  Anette Bygum; Klaus Ejner Andersen; Carsten Sauer Mikkelsen
Journal:  Eur J Dermatol       Date:  2009 Mar-Apr       Impact factor: 3.328

Review 7.  C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option.

Authors:  H J Longhurst; S Carr; K Khair
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330
  7 in total
  3 in total

Review 1.  A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).

Authors:  Konrad Bork
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

2.  Value co-creation in healthcare: evidence from innovative therapeutic alternatives for hereditary angioedema.

Authors:  Rosanna Spanò; Nadia Di Paola; Maria Bova; Alessandro Barbarino
Journal:  BMC Health Serv Res       Date:  2018-07-20       Impact factor: 2.655

3.  Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy.

Authors:  William Lumry; Teri Templeton; Laurel Omert; Donald Levy
Journal:  J Infus Nurs       Date:  2020 May/Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.